HK Stock Price Fluctuated | COFCO JOYCOME (01610) is now up more than 4%. The National Development and Reform Commission predicts a slight decrease in short-term pork prices, but a rebound is still possible in the future.
Connecting global capital markets
COFCO JOYCOME (01610) rose more than 4% in early trading and rose 3.91% to HKD 1.86 at the time of publication, with a transaction volume of HKD 17.436 million.
On the news front, according to the National Development and Reform Commission, due to the strong cooling effect, the pickling activities in some southwestern regions have gradually started, and the speed of product shipment has increased compared to the previous period. At the same time, the rising prices of fattened pigs have driven the prices of standard pigs and spread to the northern market, stimulating the market's reluctance to sell, causing a slight increase in pig prices. Currently, the operating rate of northern slaughterhouses is increasing slowly, with a strong intention to lower prices. It is expected that short-term pig prices may reach their peak and then slightly decrease. However, as home pickling and sausage-making activities gradually start in the later period, there is still a possibility of a rebound in pig prices.
It is noteworthy that industry insiders have stated that the impact of pig diseases is gradually weakening. Due to the low pig prices, there has been some relaxation in biological control measures, resulting in outbreaks of pig diseases in many areas of the north, but mainly in small and medium-scale pig farms. The impact on the overall market is relatively small, with a significant decrease in sales by individual households, while groups and large factories are practically unaffected. This also indirectly indicates that large-scale pig farms have accumulated a certain amount of experience in disease prevention and control, and currently the elimination of sows has a relatively small impact on the overall market.
Related Articles

HK Stock Market Move | AKESO (09926) rose more than 7% in early trading. The company's first dual-immune ADC drug AK146D1 entered clinical trials.

HK Stock Market Move | SIMCERE PHARMA(02096) rises more than 3%. The new generation of anti-VEGF monoclonal antibody "Suvixitumab monoclonal antibody" has been approved for listing.

HK Stock Market Move | Gambling stocks continue to rise, Macau's gambling revenue in June exceeded expectations, Citigroup expects the growth momentum to continue in the second half of the year.
HK Stock Market Move | AKESO (09926) rose more than 7% in early trading. The company's first dual-immune ADC drug AK146D1 entered clinical trials.

HK Stock Market Move | SIMCERE PHARMA(02096) rises more than 3%. The new generation of anti-VEGF monoclonal antibody "Suvixitumab monoclonal antibody" has been approved for listing.

HK Stock Market Move | Gambling stocks continue to rise, Macau's gambling revenue in June exceeded expectations, Citigroup expects the growth momentum to continue in the second half of the year.

RECOMMEND

U.S. Senate Passes “Big and Beautiful” Bill, Triggering Surge in Gold Amid Soaring Deficit Concerns
02/07/2025

Declining Demand Triggers Price Drop; Photovoltaic Glass Industry May Be Preparing for a New Round of Coordinated Production Cuts
02/07/2025

Surge in Prices of Chinese-Made Goods Highlights Tariff Impact on U.S. Consumers
02/07/2025